Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

直到某次感冒反复不愈住院检查，医生提醒她不仅是“普通咳嗽”，很可能是 慢性肺功能下降 在不断累积风险。 本文将分享 肺病患者寿命较短的5个常见特点 ，帮你了解哪些情况更需要警惕，并给出可执行的对策建议。

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

Select your location to view local American Lung Association events and news near you.

COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...

NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...